Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET
Company Participants
Matt Hall – Director, Corporate Development & Investor Relations
Cheryl Blanchard – President & Chief Executive Officer
Steve Griffin – Executive Vice President, Chief Financial Officer & Treasurer
Conference Call Participants
Jim Sidoti – Sidoti & Co.
Mike Petusky – Barrington Research
Operator
Good morning, ladies and gentlemen, and welcome to Anika’s Fourth Quarter and Year End Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] Also note that this call is being recorded on Wednesday, March 12, 2025.
I will now turn the call over to Matt Hall, Director, Corporate Development and Investor Relations. Please go ahead, sir.
Matt Hall
Thank you, Sylvie. Good evening, and thank you for joining us for Anika’s fourth quarter and year end 2024 conference call and webcast. I’m Matt Hall, Anika’s Director of Corporate Development and Investor Relations.
Our earnings press release was issued earlier this afternoon and is available on our Investor Relations website located at www.anika.com as are the supplementary PowerPoint slides that will be used for the discussion today.
With me on the call today are Dr. Cheryl Blanchard, President and Chief Executive Officer; and Steve Griffin, Executive Vice President, Chief Financial Officer and Treasurer, who will present our fourth quarter and year-end 2024 financial results and business highlights.
Please take a moment and open the slide presentation and refer to slide number two. Before we begin, please understand that certain statements made during the call today constitute forward-looking statements as defined in the Securities Exchange Act of 1934. These statements are based on our current beliefs and expectations and are subject to certain risks and uncertainties.
The company’s
Read the full article here
